We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Down. 4 | LSE:DI4O | London | Ordinary Share | GB00B02WQ616 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 28.25 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jun 2019 to Jun 2024
The Biotech Growth Trust PLC
Hot Features
Premium
1 March 2013
The Biotech Growth Trust PLC
Voting Rights and Capital
In accordance with the Financial Services Authority's Disclosure and Transparency Rules, The Biotech Growth Trust PLC announces the following:
As at 28 February 2013, The Biotech Growth Trust PLC's capital consists of ordinary shares of 25p with each ordinary share holding one voting right. The total number of ordinary shares in issue is 63,356,347. The Company has no ordinary shares in Treasury.
Therefore, the total number of voting rights in The Biotech Growth Trust PLC is 63,356,347.
The above figure (63,356,347) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in The Biotech Growth Trust PLC, or a change to their interest in The Biotech Growth Trust PLC, under the Financial Services Authority's Disclosure and Transparency Rules.
- END - Frostrow Capital LLP Company Secretary Tel: 0203 008 4913
Copyright ch 1 PR Newswire
1 Year Down. 4 Chart |
1 Month Down. 4 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
